Research Directory

Focus on ophthalmology: new treatment modality

Friday 27 April 2012

Interviewee/Contributer: Patrik De Haes

Organisation: ThromboGenics NV
- Policy & Regulation
- Strategy
Read more

Organisations

more organisations...

Interviewees and Contributers

more interviewees...

Select a News Category

Recent Appointments

Pascale Witz to head strategic development at Sanofi

Monday May 6 2013

Srinivas Akkaraju joins Sofinnova Ventures

Monday May 6 2013

Vicente Anido nominated to Nicox board

Monday May 6 2013

Jeremy Farrar named director of the Wellcome Trust

Monday May 6 2013

Harry Kirsch becomes CFO at Novartis

Monday May 6 2013